ArticleJournal of acquired immune deficiency syndromes (1999)2026

Brief Report: Real-World Uptake and Clinical Outcomes of Long-Acting Injectable Cabotegravir/Rilpivirine in the United States, 2021-2023.

Jesse O'Shea et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.